CCL2 and neoplasm: Evidence shows that TAMs secret multiple immunosuppressive mediators, such as transforming growth factor (TGF)-B1 and interleukin-10 (IL-10), CCL2-CCR2 pathways, play a crucial role in hindering immunotherapy efficiency tumor and promoting tumor progression (40–43).